{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:46:31Z","timestamp":1775864791765,"version":"3.50.1"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A5A2030333"],"award-info":[{"award-number":["NRF-2021R1A5A2030333"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"publisher","award":["GCU-202300540001"],"award-info":[{"award-number":["GCU-202300540001"]}],"id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"DOI":"10.1007\/s00281-026-01071-2","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:55:15Z","timestamp":1775818515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytokine-mediated, organ-specific immune modulation and dysregulation of innate lymphocytes in sepsis"],"prefix":"10.1007","volume":"48","author":[{"given":"Seoyeon","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sejong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2638-5749","authenticated-orcid":false,"given":"Seungwon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"3","key":"1071_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C et al (2016) Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med 193(3):259\u2013272","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1071_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nrneph.2015.66","volume":"11","author":"AM Drewry","year":"2015","unstructured":"Drewry AM, Hotchkiss RS (2015) Sepsis: revising definitions of sepsis. Nat Rev Nephrol 11(6):326\u2013328","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1071_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/imr.12499","volume":"274","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA (2016) The immune system\u2019s role in sepsis progression, resolution, and long-term outcome. Immunol Rev 274(1):330\u2013353","journal-title":"Immunol Rev"},{"issue":"8","key":"1071_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M et al (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8):801\u2013810","journal-title":"JAMA"},{"issue":"4","key":"1071_CR5","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s15010-024-02181-5","volume":"52","author":"S Piedmont","year":"2024","unstructured":"Piedmont S et al (2024) Sepsis incidence, suspicion, prediction and mortality in emergency medical services: a cohort study related to the current international sepsis guideline. Infection 52(4):1325\u20131335","journal-title":"Infection"},{"issue":"10219","key":"1071_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE et al (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395(10219):200\u2013211","journal-title":"Lancet"},{"key":"1071_CR7","unstructured":"World Health Organization Sepsis. Sepsis 2024 [cited 2025 July 11]; Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sepsis"},{"issue":"1","key":"1071_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","volume":"23","author":"JL Vincent","year":"2019","unstructured":"Vincent JL et al (2019) Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care 23(1):196","journal-title":"Crit Care"},{"key":"1071_CR9","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS et al (2016) Sepsis and septic shock. Nat Rev Dis Primers 2:16045","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"1071_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nm.2156","volume":"16","author":"JC Alves-Filho","year":"2010","unstructured":"Alves-Filho JC et al (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16(6):708\u2013712","journal-title":"Nat Med"},{"issue":"2","key":"1071_CR11","first-page":"134","volume":"12","author":"S Liu","year":"2024","unstructured":"Liu S et al (2024) ADAR1 Inhibits Macrophage Apoptosis and Alleviates Sepsis-induced Liver Injury Through miR-122\/BCL2A1 Signaling. J Clin Transl Hepatol 12(2):134\u2013150","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"1071_CR12","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41467-025-56524-3","volume":"16","author":"T Roh","year":"2025","unstructured":"Roh T et al (2025) Fucosylated haptoglobin promotes inflammation via Mincle in sepsis: an observational study. Nat Commun 16(1):1342","journal-title":"Nat Commun"},{"issue":"1","key":"1071_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","volume":"9","author":"M Cao","year":"2023","unstructured":"Cao M, Wang G, Xie J (2023) Immune dysregulation in sepsis: experiences, lessons and perspectives. Cell Death Discov 9(1):465","journal-title":"Cell Death Discov"},{"issue":"4","key":"1071_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ni.3398","volume":"17","author":"SC Cheng","year":"2016","unstructured":"Cheng SC et al (2016) Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol 17(4):406\u2013413","journal-title":"Nat Immunol"},{"key":"1071_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071011","author":"C Nedeva","year":"2021","unstructured":"Nedeva C (2021) Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis. Biomolecules. https:\/\/doi.org\/10.3390\/biom11071011","journal-title":"Biomolecules"},{"key":"1071_CR16","doi-asserted-by":"publisher","first-page":"1568875","DOI":"10.3389\/fimmu.2025.1568875","volume":"16","author":"LC Bento","year":"2025","unstructured":"Bento LC et al (2025) Innate lymphoid cells in bone marrow and peripheral blood of healthy individuals and in bone marrow of patients with myelodysplastic syndromes. Front Immunol 16:1568875","journal-title":"Front Immunol"},{"issue":"6263","key":"1071_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1126\/science.aac9593","volume":"350","author":"G Gasteiger","year":"2015","unstructured":"Gasteiger G et al (2015) Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350(6263):981\u2013985","journal-title":"Science"},{"issue":"6","key":"1071_CR18","first-page":"1198","volume":"164","author":"X Fan","year":"2016","unstructured":"Fan X, Rudensky AY (2016) Hallmarks Tissue-Resident Lymphocytes Cell 164(6):1198\u20131211","journal-title":"Hallmarks Tissue-Resident Lymphocytes Cell"},{"key":"1071_CR19","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3389\/fimmu.2018.02104","volume":"9","author":"C Chou","year":"2018","unstructured":"Chou C, Li MO (2018) Tissue-Resident Lymphocytes Across Innate and Adaptive Lineages. Front Immunol 9:2104","journal-title":"Front Immunol"},{"issue":"2","key":"1071_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4049\/jimmunol.2200074","volume":"209","author":"L Van Kaer","year":"2022","unstructured":"Van Kaer L et al (2022) Innate and Innate-like Effector Lymphocytes in Health and Disease. J Immunol 209(2):199\u2013207","journal-title":"J Immunol"},{"issue":"7","key":"1071_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nm.3892","volume":"21","author":"GF Sonnenberg","year":"2015","unstructured":"Sonnenberg GF, Artis D (2015) Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 21(7):698\u2013708","journal-title":"Nat Med"},{"key":"1071_CR22","doi-asserted-by":"publisher","first-page":"670676","DOI":"10.3389\/fimmu.2021.670676","volume":"12","author":"W Chen","year":"2021","unstructured":"Chen W et al (2021) Neuronal-Activated ILC2s Promote IL-17A Production in Lung gammadelta T Cells During Sepsis. Front Immunol 12:670676","journal-title":"Front Immunol"},{"key":"1071_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10100808","author":"Y Akama","year":"2020","unstructured":"Akama Y et al (2020) The Role of Innate Lymphoid Cells in the Regulation of Immune Homeostasis in Sepsis-Mediated Lung Inflammation. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics10100808","journal-title":"Diagnostics"},{"issue":"1","key":"1071_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00011-024-01978-2","volume":"74","author":"X Zhong","year":"2025","unstructured":"Zhong X et al (2025) Group 2 innate lymphoid cells derived IL-9 reduces macrophage apoptosis and attenuates acute lung injury in sepsis. Inflamm Res 74(1):38","journal-title":"Inflamm Res"},{"issue":"1","key":"1071_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10020-022-00459-8","volume":"28","author":"D Lai","year":"2022","unstructured":"Lai D et al (2022) GRK2 regulates group 2 innate lymphoid cell mobilization in sepsis. Mol Med 28(1):32","journal-title":"Mol Med"},{"issue":"1","key":"1071_CR26","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.1038\/s41467-024-51209-9","volume":"15","author":"B Xie","year":"2024","unstructured":"Xie B et al (2024) Gut-derived memory gammadelta T17 cells exacerbate sepsis-induced acute lung injury in mice. Nat Commun 15(1):6737","journal-title":"Nat Commun"},{"issue":"3","key":"1071_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41419-018-0412-5","volume":"9","author":"D Lai","year":"2018","unstructured":"Lai D et al (2018) Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis. Cell Death Dis 9(3):369","journal-title":"Cell Death Dis"},{"issue":"3","key":"1071_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/SHK.0000000000001647","volume":"55","author":"Y Akama","year":"2021","unstructured":"Akama Y et al (2021) Sepsis Induces Deregulation of IL-13 Production and PD-1 Expression in Lung Group 2 Innate Lymphoid Cells. Shock 55(3):357\u2013370","journal-title":"Shock"},{"issue":"5","key":"1071_CR29","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.4049\/jimmunol.164.5.2738","volume":"164","author":"A Matsukawa","year":"2000","unstructured":"Matsukawa A et al (2000) Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J Immunol 164(5):2738\u20132744","journal-title":"J Immunol"},{"issue":"6","key":"1071_CR30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.20142224","volume":"212","author":"JA Walker","year":"2015","unstructured":"Walker JA et al (2015) Bcl11b is essential for group 2 innate lymphoid cell development. J Exp Med 212(6):875\u2013882","journal-title":"J Exp Med"},{"issue":"12","key":"1071_CR31","doi-asserted-by":"publisher","first-page":"e1008140","DOI":"10.1371\/journal.ppat.1008140","volume":"15","author":"D Tripathi","year":"2019","unstructured":"Tripathi D et al (2019) IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis. PLoS Pathog 15(12):e1008140","journal-title":"PLoS Pathog"},{"key":"1071_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fimmu.2019.00092","volume":"10","author":"A Ardain","year":"2019","unstructured":"Ardain A et al (2019) Type 3 ILCs in Lung Disease. Front Immunol 10:92","journal-title":"Front Immunol"},{"key":"1071_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2025.2469207","author":"R Shao","year":"2025","unstructured":"Shao R et al (2025) LAMP2-FLOT2 interaction enhances autophagosome-lysosome fusion to protect the septic heart in response to ILC2. Autophagy. https:\/\/doi.org\/10.1080\/15548627.2025.2469207","journal-title":"Autophagy"},{"issue":"6","key":"1071_CR34","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.7150\/thno.51648","volume":"11","author":"WY Chen","year":"2021","unstructured":"Chen WY et al (2021) Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Theranostics 11(6):2594\u20132611","journal-title":"Theranostics"},{"issue":"11","key":"1071_CR35","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jacc.2021.07.018","volume":"78","author":"X Yu","year":"2021","unstructured":"Yu X et al (2021) Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction. J Am Coll Cardiol 78(11):1127\u20131142","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1071_CR36","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/cvr\/cvac144","volume":"119","author":"T Liu","year":"2023","unstructured":"Liu T et al (2023) Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells. Cardiovasc Res 119(4):1046\u20131061","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1071_CR37","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1038\/s41467-020-19297-5","volume":"11","author":"J Liu","year":"2020","unstructured":"Liu J et al (2020) Eosinophils improve cardiac function after myocardial infarction. Nat Commun 11(1):6396","journal-title":"Nat Commun"},{"issue":"7","key":"1071_CR38","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1681\/ASN.2016080877","volume":"28","author":"JH Riedel","year":"2017","unstructured":"Riedel JH et al (2017) IL-33-Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis. J Am Soc Nephrol 28(7):2068\u20132080","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1071_CR39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs A et al (2013) Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38(4):769\u2013781","journal-title":"Immunity"},{"issue":"12","key":"1071_CR40","doi-asserted-by":"publisher","first-page":"114948","DOI":"10.1016\/j.celrep.2024.114948","volume":"43","author":"M Lebrusant-Fernandez","year":"2024","unstructured":"Lebrusant-Fernandez M et al (2024) IFN-gamma-dependent regulation of intestinal epithelial homeostasis by NKT cells. Cell Rep 43(12):114948","journal-title":"Cell Rep"},{"issue":"2","key":"1071_CR41","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/mi.2015.83","volume":"9","author":"JC Martin","year":"2016","unstructured":"Martin JC et al (2016) IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis. Mucosal Immunol 9(2):539\u2013549","journal-title":"Mucosal Immunol"},{"key":"1071_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jss.2021.03.043","volume":"265","author":"A Fuchs","year":"2021","unstructured":"Fuchs A et al (2021) Pseudomonas aeruginosa Pneumonia Causes a Loss of Type-3 and an Increase in Type-1 Innate Lymphoid Cells in the Gut. J Surg Res 265:212\u2013222","journal-title":"J Surg Res"},{"issue":"1","key":"1071_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.immuni.2013.10.021","volume":"40","author":"X Guo","year":"2014","unstructured":"Guo X et al (2014) Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 40(1):25\u201339","journal-title":"Immunity"},{"issue":"1","key":"1071_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12865-024-00648-6","volume":"25","author":"P Wang","year":"2024","unstructured":"Wang P et al (2024) Sepsis induced dysfunction of liver type 1 innate lymphoid cells. BMC Immunol 25(1):57","journal-title":"BMC Immunol"},{"issue":"4","key":"1071_CR45","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.4049\/jimmunol.0801463","volume":"182","author":"CK Hu","year":"2009","unstructured":"Hu CK et al (2009) The role of hepatic invariant NKT cells in systemic\/local inflammation and mortality during polymicrobial septic shock. J Immunol 182(4):2467\u20132475","journal-title":"J Immunol"},{"key":"1071_CR46","doi-asserted-by":"publisher","first-page":"1149506","DOI":"10.3389\/fcimb.2023.1149506","volume":"13","author":"J Wan","year":"2023","unstructured":"Wan J et al (2023) Infiltrated IL-17A-producing gamma delta T cells play a protective role in sepsis-induced liver injury and are regulated by CCR6 and gut commensal microbes. Front Cell Infect Microbiol 13:1149506","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1071_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1084\/jem.20170449","volume":"215","author":"MT Stier","year":"2018","unstructured":"Stier MT et al (2018) IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow. J Exp Med 215(1):263\u2013281","journal-title":"J Exp Med"},{"key":"1071_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.imlet.2016.01.007","volume":"179","author":"E Montaldo","year":"2016","unstructured":"Montaldo E et al (2016) Human innate lymphoid cells. Immunol Lett 179:2\u20138","journal-title":"Immunol Lett"},{"issue":"5","key":"1071_CR49","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.jaci.2021.03.015","volume":"147","author":"KR Bartemes","year":"2021","unstructured":"Bartemes KR, Kita H (2021) Roles of innate lymphoid cells (ILCs) in allergic diseases: the 10-year anniversary for ILC2s. J Allergy Clin Immunol 147(5):1531\u20131547","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1071_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41423-020-0399-6","volume":"17","author":"S Zhou","year":"2020","unstructured":"Zhou S et al (2020) The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases. Cell Mol Immunol 17(4):335\u2013346","journal-title":"Cell Mol Immunol"},{"key":"1071_CR51","doi-asserted-by":"publisher","first-page":"789788","DOI":"10.3389\/fimmu.2021.789788","volume":"12","author":"AS Clottu","year":"2021","unstructured":"Clottu AS et al (2021) Innate Lymphoid Cells in Autoimmune Diseases. Front Immunol 12:789788","journal-title":"Front Immunol"},{"issue":"3","key":"1071_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41590-022-01127-z","volume":"23","author":"N Jacquelot","year":"2022","unstructured":"Jacquelot N et al (2022) Innate lymphoid cells and cancer. Nat Immunol 23(3):371\u2013379","journal-title":"Nat Immunol"},{"issue":"2","key":"1071_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.trecan.2022.10.007","volume":"9","author":"CK Ng","year":"2023","unstructured":"Ng CK, Belz GT (2023) Innate lymphoid cells: potential targets for cancer therapeutics. Trends Cancer 9(2):158\u2013171","journal-title":"Trends Cancer"},{"key":"1071_CR54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fimmu.2015.00416","volume":"6","author":"N von Burg","year":"2015","unstructured":"von Burg N, Turchinovich G, Finke D (2015) Maintenance of Immune Homeostasis through ILC\/T Cell Interactions. Front Immunol 6:416","journal-title":"Front Immunol"},{"issue":"1","key":"1071_CR55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5114\/aoms.2019.89835","volume":"17","author":"A Poniewierska-Baran","year":"2021","unstructured":"Poniewierska-Baran A, Tokarz-Deptula B, Deptula W (2021) The role of innate lymphoid cells in selected disease states - cancer formation, metabolic disorder and inflammation. Arch Med Sci 17(1):196\u2013206","journal-title":"Arch Med Sci"},{"issue":"1","key":"1071_CR56","doi-asserted-by":"publisher","first-page":"e1008299","DOI":"10.1371\/journal.ppat.1008299","volume":"17","author":"AH Lopez-Yglesias","year":"2021","unstructured":"Lopez-Yglesias AH et al (2021) T-bet-dependent ILC1- and NK cell-derived IFN-gamma mediates cDC1-dependent host resistance against Toxoplasma gondii. PLoS Pathog 17(1):e1008299","journal-title":"PLoS Pathog"},{"issue":"6","key":"1071_CR57","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","volume":"105","author":"I Prager","year":"2019","unstructured":"Prager I, Watzl C (2019) Mechanisms of natural killer cell-mediated cellular cytotoxicity. J Leukoc Biol 105(6):1319\u20131329","journal-title":"J Leukoc Biol"},{"key":"1071_CR58","doi-asserted-by":"crossref","unstructured":"Bai L et al (2021) Liver type 1 innate lymphoid cells develop locally via an interferon-gamma-dependent loop. Science, 371(6536)","DOI":"10.1126\/science.aba4177"},{"key":"1071_CR59","doi-asserted-by":"publisher","first-page":"e01659","DOI":"10.7554\/eLife.01659","volume":"3","author":"DK Sojka","year":"2014","unstructured":"Sojka DK et al (2014) Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife 3:e01659","journal-title":"Elife"},{"issue":"1","key":"1071_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.immuni.2016.06.024","volume":"45","author":"T Nabekura","year":"2016","unstructured":"Nabekura T, Lanier LL (2016) Activating receptors for self-MHC class I enhance effector functions and memory differentiation of NK cells during mouse cytomegalovirus infection. Immunity 45(1):74\u201382","journal-title":"Immunity"},{"issue":"1","key":"1071_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1189\/jlb.3A0516-225R","volume":"101","author":"PD Krueger","year":"2017","unstructured":"Krueger PD et al (2017) Murine liver-resident group 1 innate lymphoid cells regulate optimal priming of anti-viral CD8\u2009+\u2009T cells. J Leukoc Biol 101(1):329\u2013338","journal-title":"J Leukoc Biol"},{"issue":"3","key":"1071_CR62","doi-asserted-by":"publisher","first-page":"112269","DOI":"10.1016\/j.celrep.2023.112269","volume":"42","author":"MO Jakob","year":"2023","unstructured":"Jakob MO et al (2023) ILC3s restrict the dissemination of intestinal bacteria to safeguard liver regeneration after surgery. Cell Rep 42(3):112269","journal-title":"Cell Rep"},{"key":"1071_CR63","doi-asserted-by":"publisher","first-page":"742571","DOI":"10.3389\/fimmu.2022.742571","volume":"13","author":"JJ Siegler","year":"2022","unstructured":"Siegler JJ et al (2022) Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer Cells. Front Immunol 13:742571","journal-title":"Front Immunol"},{"key":"1071_CR64","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.coi.2016.01.006","volume":"39","author":"Q Yang","year":"2016","unstructured":"Yang Q, Bhandoola A (2016) The development of adult innate lymphoid cells. Curr Opin Immunol 39:114\u2013120","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"1071_CR65","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.immuni.2018.05.013","volume":"48","author":"M Colonna","year":"2018","unstructured":"Colonna M (2018) Innate lymphoid cells: diversity, plasticity, and unique functions in immunity. Immunity 48(6):1104\u20131117","journal-title":"Immunity"},{"key":"1071_CR66","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.3389\/fimmu.2019.02010","volume":"10","author":"T Willinger","year":"2019","unstructured":"Willinger T (2019) Metabolic Control of Innate Lymphoid Cell Migration. Front Immunol 10:2010","journal-title":"Front Immunol"},{"issue":"2","key":"1071_CR67","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaci.2022.09.022","volume":"151","author":"EM Mace","year":"2023","unstructured":"Mace EM (2023) Human natural killer cells: form, function, and development. J Allergy Clin Immunol 151(2):371\u2013385","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1071_CR68","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.immuni.2019.02.002","volume":"50","author":"MW Dahlgren","year":"2019","unstructured":"Dahlgren MW et al (2019) Adventitial stromal cells define group 2 innate lymphoid cell tissue niches. Immunity 50(3):707-722e6","journal-title":"Immunity"},{"issue":"9","key":"1071_CR69","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.20190689","volume":"216","author":"BMJ Rana","year":"2019","unstructured":"Rana BMJ et al (2019) A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissue. J Exp Med 216(9):1999\u20132009","journal-title":"J Exp Med"},{"issue":"7083","key":"1071_CR70","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature04606","volume":"440","author":"LR Shiow","year":"2006","unstructured":"Shiow LR et al (2006) CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440(7083):540\u2013544","journal-title":"Nature"},{"issue":"47","key":"1071_CR71","doi-asserted-by":"publisher","first-page":"eabq1551","DOI":"10.1126\/sciadv.abq1551","volume":"8","author":"Q Liu","year":"2022","unstructured":"Liu Q et al (2022) Identification of the niche and mobilization mechanism for tissue-protective multipotential bone marrow ILC progenitors. Sci Adv 8(47):eabq1551","journal-title":"Sci Adv"},{"key":"1071_CR72","doi-asserted-by":"crossref","unstructured":"Siempos II et al Cecal ligation and puncture-induced sepsis as a model to study autophagy in mice. J Vis Exp, 2014(84): p. e51066","DOI":"10.3791\/51066-v"},{"issue":"1","key":"1071_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nprot.2008.214","volume":"4","author":"D Rittirsch","year":"2009","unstructured":"Rittirsch D et al (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4(1):31\u201336","journal-title":"Nat Protoc"},{"issue":"1","key":"1071_CR74","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/s41467-025-57979-0","volume":"16","author":"S Kroon","year":"2025","unstructured":"Kroon S et al (2025) Sublethal systemic LPS in mice enables gut-luminal pathogens to bloom through oxygen species-mediated microbiota inhibition. Nat Commun 16(1):2760","journal-title":"Nat Commun"},{"issue":"3","key":"1071_CR75","doi-asserted-by":"publisher","first-page":"e997","DOI":"10.1002\/cpz1.997","volume":"4","author":"SK Kannan","year":"2024","unstructured":"Kannan SK et al (2024) Mouse Models of Sepsis. Curr Protoc 4(3):e997","journal-title":"Curr Protoc"},{"issue":"1","key":"1071_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5847\/wjem.j.1920-8642.2020.01.003","volume":"11","author":"YW Fan","year":"2020","unstructured":"Fan YW et al (2020) A pulmonary source of infection in patients with sepsis-associated acute kidney injury leads to a worse outcome and poor recovery of kidney function. World J Emerg Med 11(1):18\u201326","journal-title":"World J Emerg Med"},{"key":"1071_CR77","doi-asserted-by":"publisher","first-page":"1338542","DOI":"10.3389\/fmed.2024.1338542","volume":"11","author":"M Bardaji-Carrillo","year":"2024","unstructured":"Bardaji-Carrillo M et al (2024) Post-operative sepsis-induced acute respiratory distress syndrome: risk factors for a life-threatening complication. Front Med (Lausanne) 11:1338542","journal-title":"Front Med (Lausanne)"},{"key":"1071_CR78","doi-asserted-by":"publisher","first-page":"1531275","DOI":"10.3389\/fmed.2025.1531275","volume":"12","author":"L Liu","year":"2025","unstructured":"Liu L et al (2025) Clinical management of sepsis-associated acute respiratory distress syndrome: current evidence and future directions. Front Med (Lausanne) 12:1531275","journal-title":"Front Med (Lausanne)"},{"key":"1071_CR79","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1164\/ajrccm.151.2.7842182","volume":"151","author":"LD Hudson","year":"1995","unstructured":"Hudson LD, Anardi MJ, Maunder D (1995) <clinical acute=\"development=\u201d distress=\"for=\u201d of=\"respiratory=\u201d risks=\"syndrome.pdf=\u201d the=\"\u201d><\/clinical>. Am J Respir Crit Care Med 151:293\u2013301","journal-title":"Am J Respir Crit Care Med"},{"key":"1071_CR80","doi-asserted-by":"publisher","first-page":"1027984","DOI":"10.3389\/fmed.2022.1027984","volume":"9","author":"L Volkov","year":"2022","unstructured":"Volkov L et al (2022) Clinical outcomes and characteristics of critically ill patients with influenza- and COVID-19-induced ARDS: A retrospective, matched cohort study. Front Med (Lausanne) 9:1027984","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"1071_CR81","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/imcb.12159","volume":"96","author":"H Xu","year":"2018","unstructured":"Xu H et al (2018) Interleukin-33 contributes to ILC2 activation and early inflammation-associated lung injury during abdominal sepsis. Immunol Cell Biol 96(9):935\u2013947","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"1071_CR82","doi-asserted-by":"publisher","first-page":"L51","DOI":"10.1152\/ajplung.00028.2005","volume":"290","author":"J Lomas-Neira","year":"2006","unstructured":"Lomas-Neira J et al (2006) Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am J Physiol Lung Cell Mol Physiol 290(1):L51\u2013L58","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"1071_CR83","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1515\/jtim-2016-0012","volume":"6","author":"G Rawal","year":"2018","unstructured":"Rawal G, Yadav S, Kumar R (2018) Acute respiratory distress syndrome: an update and review. J Transl Int Med 6(2):74\u201377","journal-title":"J Transl Int Med"},{"issue":"11","key":"1071_CR84","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/ni.2131","volume":"12","author":"LA Monticelli","year":"2011","unstructured":"Monticelli LA et al (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12(11):1045\u20131054","journal-title":"Nat Immunol"},{"issue":"6","key":"1071_CR85","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ni.3444","volume":"17","author":"SM Bal","year":"2016","unstructured":"Bal SM et al (2016) IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol 17(6):636\u2013645","journal-title":"Nat Immunol"},{"issue":"3","key":"1071_CR86","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/thoraxjnl-2019-213613","volume":"75","author":"K Zhang","year":"2020","unstructured":"Zhang K et al (2020) RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock. Thorax 75(3):209\u2013219","journal-title":"Thorax"},{"issue":"5","key":"1071_CR87","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/SHK.0b013e318249b81d","volume":"37","author":"M Xiang","year":"2012","unstructured":"Xiang M et al (2012) Role of macrophages in mobilization of hematopoietic progenitor cells from bone marrow after hemorrhagic shock. Shock 37(5):518\u2013523","journal-title":"Shock"},{"key":"1071_CR88","first-page":"429","volume":"81","author":"JL Barlow","year":"2019","unstructured":"Barlow JL, McKenzie ANJ (2019) Innate Lymphoid Cells Lung Annu Rev Physiol 81:429\u2013452","journal-title":"Innate Lymphoid Cells Lung Annu Rev Physiol"},{"issue":"1","key":"1071_CR89","doi-asserted-by":"publisher","first-page":"25011","DOI":"10.1038\/s41598-024-76606-4","volume":"14","author":"K Fang","year":"2024","unstructured":"Fang K et al (2024) Group 2 innate lymphocytes protect the balance between autophagy and apoptosis in cardiomyocytes during sepsis-induced cardiac injury. Sci Rep 14(1):25011","journal-title":"Sci Rep"},{"issue":"3","key":"1071_CR90","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/157340311798220494","volume":"7","author":"FJ Romero-Bermejo","year":"2011","unstructured":"Romero-Bermejo FJ et al (2011) Sepsis-induced cardiomyopathy. Curr Cardiol Rev 7(3):163\u2013183","journal-title":"Curr Cardiol Rev"},{"issue":"9","key":"1071_CR91","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/08850666231180526","volume":"38","author":"D Hasegawa","year":"2023","unstructured":"Hasegawa D et al (2023) Prevalence and Prognosis of Sepsis-Induced Cardiomyopathy: A Systematic Review and Meta-Analysis. J Intensive Care Med 38(9):797\u2013808","journal-title":"J Intensive Care Med"},{"key":"1071_CR92","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/fimmu.2020.00802","volume":"11","author":"Y Deng","year":"2020","unstructured":"Deng Y et al (2020) Unique Phenotypes of Heart Resident Type 2 Innate Lymphoid Cells. Front Immunol 11:802","journal-title":"Front Immunol"},{"key":"1071_CR93","doi-asserted-by":"publisher","first-page":"742662","DOI":"10.3389\/fcell.2021.742662","volume":"9","author":"T Hong","year":"2021","unstructured":"Hong T et al (2021) IL-13 Derived Type 2 Innate Lymphocytes Ameliorates Cardiomyocyte Apoptosis Through STAT3 Signaling Pathway. Front Cell Dev Biol 9:742662","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"1071_CR94","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1161\/CIRCRESAHA.116.304269","volume":"116","author":"CC O\u2019Meara","year":"2015","unstructured":"O\u2019Meara CC et al (2015) Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration. Circ Res 116(5):804\u2013815","journal-title":"Circ Res"},{"issue":"9","key":"1071_CR95","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s44161-025-00687-1","volume":"4","author":"M Watanabe","year":"2025","unstructured":"Watanabe M et al (2025) Excessive HIF-1alpha driven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxia. Nat Cardiovasc Res 4(9):1077\u20131093","journal-title":"Nat Cardiovasc Res"},{"issue":"12","key":"1071_CR96","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s42255-022-00685-8","volume":"4","author":"L Zhou","year":"2022","unstructured":"Zhou L, Lin Q, Sonnenberg GF (2022) Metabolic control of innate lymphoid cells in health and disease. Nat Metab 4(12):1650\u20131659","journal-title":"Nat Metab"},{"issue":"6","key":"1071_CR97","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","volume":"19","author":"A Zarbock","year":"2023","unstructured":"Zarbock A et al (2023) Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol 19(6):401\u2013417","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1071_CR98","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13054-025-05351-5","volume":"29","author":"T Takeuchi","year":"2025","unstructured":"Takeuchi T et al (2025) Epidemiology of sepsis-associated acute kidney injury in the ICU with contemporary consensus definitions. Crit Care 29(1):128","journal-title":"Crit Care"},{"issue":"9","key":"1071_CR99","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00134-023-07138-0","volume":"49","author":"KC White","year":"2023","unstructured":"White KC et al (2023) Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study. Intensive Care Med 49(9):1079\u20131089","journal-title":"Intensive Care Med"},{"key":"1071_CR100","doi-asserted-by":"publisher","first-page":"688647","DOI":"10.3389\/fimmu.2021.688647","volume":"12","author":"R Nagashima","year":"2021","unstructured":"Nagashima R, Iyoda M (2021) The Roles of Kidney-Resident ILC2 in Renal Inflammation and Fibrosis. Front Immunol 12:688647","journal-title":"Front Immunol"},{"key":"1071_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041544","author":"WY Chen","year":"2020","unstructured":"Chen WY et al (2020) Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21041544","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1071_CR102","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1038\/s41598-019-39886-9","volume":"9","author":"V Sabapathy","year":"2019","unstructured":"Sabapathy V et al (2019) A Novel Hybrid Cytokine IL233 Mediates regeneration following Doxorubicin-Induced Nephrotoxic Injury. Sci Rep 9(1):3215","journal-title":"Sci Rep"},{"issue":"13","key":"1071_CR103","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/CM9.0000000000003630","volume":"138","author":"W Shang","year":"2025","unstructured":"Shang W et al (2025) Gut microbiota: A novel target for sepsis treatment. Chin Med J (Engl) 138(13):1513\u20131515","journal-title":"Chin Med J (Engl)"},{"key":"1071_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13206082","author":"A Piccioni","year":"2024","unstructured":"Piccioni A et al (2024) The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm13206082","journal-title":"Journal of Clinical Medicine"},{"issue":"5","key":"1071_CR105","doi-asserted-by":"publisher","first-page":"e1006373","DOI":"10.1371\/journal.ppat.1006373","volume":"13","author":"B Kramer","year":"2017","unstructured":"Kramer B et al (2017) Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy. PLoS Pathog 13(5):e1006373","journal-title":"PLoS Pathog"},{"key":"1071_CR106","doi-asserted-by":"publisher","first-page":"1146077","DOI":"10.3389\/fimmu.2023.1146077","volume":"14","author":"AA Korchagina","year":"2023","unstructured":"Korchagina AA et al (2023) Transcriptional control of ILC identity. Front Immunol 14:1146077","journal-title":"Front Immunol"},{"issue":"1","key":"1071_CR107","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink JH et al (2015) Interleukin-12 and \u2212 23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43(1):146\u201360","journal-title":"Immunity"},{"key":"1071_CR108","doi-asserted-by":"publisher","first-page":"1575554","DOI":"10.3389\/fimmu.2025.1575554","volume":"16","author":"X Xu","year":"2025","unstructured":"Xu X et al (2025) Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategies. Front Immunol 16:1575554","journal-title":"Front Immunol"},{"issue":"1","key":"1071_CR109","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13054-022-04176-w","volume":"26","author":"C Lorencio Cardenas","year":"2022","unstructured":"Lorencio Cardenas C et al (2022) Trends in mortality in septic patients according to the different organ failure during 15 years. Crit Care 26(1):302","journal-title":"Crit Care"},{"issue":"4","key":"1071_CR110","doi-asserted-by":"publisher","first-page":"547","DOI":"10.17219\/acem\/68363","volume":"27","author":"EA Woznica","year":"2018","unstructured":"Woznica EA et al (2018) Liver dysfunction in sepsis. Adv Clin Exp Med 27(4):547\u2013551","journal-title":"Adv Clin Exp Med"},{"key":"1071_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413415","author":"A Shahid","year":"2024","unstructured":"Shahid A et al (2024) Gut Microbiota and Liver Dysfunction in Sepsis: The Role of Inflammatory Mediators and Therapeutic Approaches. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252413415","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1071_CR112","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.immuni.2023.12.013","volume":"57","author":"E Narni-Mancinelli","year":"2024","unstructured":"Narni-Mancinelli E, Berruyer C, Vivier E (2024) On blood and tissue-resident natural killer cells. Immunity 57(1):6\u20138","journal-title":"Immunity"},{"key":"1071_CR113","doi-asserted-by":"publisher","first-page":"1101918","DOI":"10.3389\/fimmu.2023.1101918","volume":"14","author":"F Wang","year":"2023","unstructured":"Wang F et al (2023) Natural killer cells in sepsis: friends or foes? Front Immunol 14:1101918","journal-title":"Front Immunol"},{"key":"1071_CR114","unstructured":"Chaudhry H et al (2013) Role of cytokines as a double-edged sword in sepsis. In Vivo 27(6):669\u2013684"},{"issue":"5","key":"1071_CR115","doi-asserted-by":"publisher","first-page":"R243","DOI":"10.1186\/cc10501","volume":"15","author":"D Andaluz-Ojeda","year":"2011","unstructured":"Andaluz-Ojeda D et al (2011) Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 15(5):R243","journal-title":"Crit Care"},{"issue":"3","key":"1071_CR116","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.4049\/jimmunol.1601486","volume":"198","author":"Y Guo","year":"2017","unstructured":"Guo Y et al (2017) IL-15 Enables Septic Shock by Maintaining NK Cell Integrity and Function. J Immunol 198(3):1320\u20131333","journal-title":"J Immunol"},{"issue":"3","key":"1071_CR117","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/cc9031","volume":"14","author":"C Gogos","year":"2010","unstructured":"Gogos C et al (2010) Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care 14(3):R96","journal-title":"Crit Care"},{"issue":"4","key":"1071_CR118","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/apm.12002","volume":"121","author":"G Giannikopoulos","year":"2013","unstructured":"Giannikopoulos G et al (2013) The functional role of natural killer cells early in clinical sepsis. APMIS 121(4):329\u2013336","journal-title":"APMIS"},{"issue":"8","key":"1071_CR119","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.7150\/thno.49288","volume":"11","author":"M Garzon-Tituana","year":"2021","unstructured":"Garzon-Tituana M et al (2021) Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis. Theranostics 11(8):3781\u20133795","journal-title":"Theranostics"},{"issue":"3","key":"1071_CR120","doi-asserted-by":"publisher","first-page":"R112","DOI":"10.1186\/cc11404","volume":"16","author":"JS Boomer","year":"2012","unstructured":"Boomer JS et al (2012) A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care 16(3):R112","journal-title":"Crit Care"},{"key":"1071_CR121","doi-asserted-by":"publisher","first-page":"696536","DOI":"10.3389\/fimmu.2021.696536","volume":"12","author":"DB Darden","year":"2021","unstructured":"Darden DB et al (2021) A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis. Front Immunol 12:696536","journal-title":"Front Immunol"},{"issue":"12","key":"1071_CR122","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1046\/j.1469-0691.2000.00175.x","volume":"6","author":"M Holub","year":"2000","unstructured":"Holub M et al (2000) Changes in lymphocyte subpopulations and CD3+\/DR+ expression in sepsis. Clin Microbiol Infect 6(12):657\u2013660","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1071_CR123","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4049\/jimmunol.0902307","volume":"184","author":"S Inoue","year":"2010","unstructured":"Inoue S et al (2010) IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J Immunol 184(3):1401\u20131409","journal-title":"J Immunol"},{"issue":"6","key":"1071_CR124","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.4049\/jimmunol.2001131","volume":"206","author":"IJ Jensen","year":"2021","unstructured":"Jensen IJ et al (2021) NK Cell-Derived IL-10 Supports Host Survival during Sepsis. J Immunol 206(6):1171\u20131180","journal-title":"J Immunol"},{"issue":"6","key":"1071_CR125","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4110\/in.2017.17.6.365","volume":"17","author":"DI Kwon","year":"2017","unstructured":"Kwon DI, Lee YJ (2017) Lineage differentiation program of invariant natural killer T cells. Immune Netw 17(6):365\u2013377","journal-title":"Immune Netw"},{"key":"1071_CR126","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3389\/fimmu.2018.02205","volume":"9","author":"S Ryu","year":"2018","unstructured":"Ryu S et al (2018) Lipid-Reactive T Cells in Immunological Disorders of the Lung. Front Immunol 9:2205","journal-title":"Front Immunol"},{"issue":"9","key":"1071_CR127","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s12276-023-01024-x","volume":"55","author":"D Jeong","year":"2023","unstructured":"Jeong D, Woo YD, Chung DH (2023) Invariant natural killer T cells in lung diseases. Exp Mol Med 55(9):1885\u20131894","journal-title":"Exp Mol Med"},{"issue":"10","key":"1071_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0329-9","volume":"51","author":"Y Qin","year":"2019","unstructured":"Qin Y et al (2019) Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells. Exp Mol Med 51(10):1\u20139","journal-title":"Exp Mol Med"},{"key":"1071_CR129","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2015.00316","volume":"6","author":"I Marrero","year":"2015","unstructured":"Marrero I, Ware R, Kumar V (2015) Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer. Front Immunol 6:316","journal-title":"Front Immunol"},{"key":"1071_CR130","doi-asserted-by":"publisher","first-page":"898473","DOI":"10.3389\/fimmu.2022.898473","volume":"13","author":"J Yang Zhou","year":"2022","unstructured":"Yang Zhou J et al (2022) Identification and Isolation of Type II NKT Cell Subsets in Human Blood and Liver. Front Immunol 13:898473","journal-title":"Front Immunol"},{"key":"1071_CR131","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fimmu.2018.00314","volume":"9","author":"S Kato","year":"2018","unstructured":"Kato S, Berzofsky JA, Terabe M (2018) Possible therapeutic application of targeting type II natural killer T cell-mediated suppression of tumor immunity. Front Immunol 9:314","journal-title":"Front Immunol"},{"key":"1071_CR132","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.2147\/JIR.S512652","volume":"18","author":"H Wang","year":"2025","unstructured":"Wang H et al (2025) Deciphering the Role of Innate Lymphoid Cells Group 3 in the Gut Microenvironment: A Narrative Review of Their Novel Contributions to Autoimmune Disease Pathogenesis. J Inflamm Res 18:5741\u20135757","journal-title":"J Inflamm Res"},{"issue":"6","key":"1071_CR133","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/jleuko\/qiad149","volume":"115","author":"CC Gray","year":"2024","unstructured":"Gray CC et al (2024) VISTA nonredundantly regulates proliferation and CD69low gammadelta T cell accumulation in the intestine in murine sepsis. J Leukoc Biol 115(6):1005\u20131019","journal-title":"J Leukoc Biol"},{"issue":"3","key":"1071_CR134","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1189\/jlb.0707507","volume":"83","author":"J Tschop","year":"2008","unstructured":"Tschop J et al (2008) Gammadelta T cells mitigate the organ injury and mortality of sepsis. J Leukoc Biol 83(3):581\u2013588","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1071_CR135","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.immuni.2013.06.015","volume":"39","author":"BS Sheridan","year":"2013","unstructured":"Sheridan BS et al (2013) gammadelta T cells exhibit multifunctional and protective memory in intestinal tissues. Immunity 39(1):184\u2013195","journal-title":"Immunity"},{"key":"1071_CR136","doi-asserted-by":"publisher","first-page":"585319","DOI":"10.3389\/fimmu.2020.585319","volume":"11","author":"C De Salvo","year":"2020","unstructured":"De Salvo C, Buela KA, Pizarro TT (2020) Cytokine-Mediated Regulation of Innate Lymphoid Cell Plasticity in Gut Mucosal Immunity. Front Immunol 11:585319","journal-title":"Front Immunol"},{"issue":"1","key":"1071_CR137","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","volume":"8","author":"Y Hu","year":"2023","unstructured":"Hu Y et al (2023) gammadelta T cells: origin and fate, subsets, diseases and immunotherapy. Signal Transduct Target Ther 8(1):434","journal-title":"Signal Transduct Target Ther"},{"key":"1071_CR138","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2147\/JIR.S307305","volume":"14","author":"I Rumienczyk","year":"2021","unstructured":"Rumienczyk I et al (2021) Multi-Organ Transcriptome Dynamics in a Mouse Model of Cecal Ligation and Puncture-Induced Polymicrobial Sepsis. J Inflamm Res 14:2377\u20132388","journal-title":"J Inflamm Res"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-026-01071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00281-026-01071-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-026-01071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:02:00Z","timestamp":1775862120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00281-026-01071-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1007\/s00281-026-01071-2","relation":{},"ISSN":["1863-2300"],"issn-type":[{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}